{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:50:30Z","timestamp":1793753430670,"version":"4.6.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"vor","delay-in-days":36,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.jcmgh.2021.02.002","type":"journal-article","created":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T01:14:48Z","timestamp":1613438088000},"page":"159-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Targeting Cholesterol Metabolism as Efficient Antiviral Strategy Against the Hepatitis E Virus"],"prefix":"10.1016","volume":"12","author":[{"given":"Mirco","family":"Glitscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Heiler","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Woytinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denna","family":"Tabari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C.","family":"Stingl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Seelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Hildt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2021.02.002_bib1","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1099\/jgv.0.000940","article-title":"Ictv Report Consortium. ICTV virus taxonomy profile: hepeviridae","volume":"98","author":"Purdy","year":"2017","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-3148.2006.00652.x","article-title":"Transfusion-transmitted hepatitis E in a \u2018nonhyperendemic\u2019 country","volume":"16","author":"Boxall","year":"2006","journal-title":"Transfus Med"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib3","first-page":"e4886","article-title":"Public health risks associated with hepatitis E virus (HEV) as a food-borne pathogen","volume":"15","author":"Ricci","year":"2017","journal-title":"EFSA J"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1155\/2007\/289059","article-title":"Serological evidence of hepatitis E virus infection in an indigenous North American population","volume":"21","author":"Minuk","year":"2007","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib5","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/jmv.23526","article-title":"Hepatitis E virus infection in Latin America: a review","volume":"85","author":"Echevarr\u00eda","year":"2013","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib6","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib7","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/hep.25505","article-title":"The global burden of hepatitis E virus genotypes 1 and 2 in 2005","volume":"55","author":"Rein","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-147-1-200707030-00005","article-title":"Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection","volume":"147","author":"Patra","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/TP.0000000000001908","article-title":"Summary of the British Transplantation Society UK Guidelines for Hepatitis E and Solid Organ Transplantation","volume":"102","author":"McPherson","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jceh.2013.05.003","article-title":"Chronic hepatitis e virus infection and treatment","volume":"3","author":"Kamar","year":"2013","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib11","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1038\/s41467-018-07200-2","article-title":"Genotype specific pathogenicity of hepatitis E virus at the human maternal-fetal interface","volume":"9","author":"Gouilly","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2016.05.002","article-title":"Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity","volume":"65","author":"Debing","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib13","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/ndt\/gfq282","article-title":"Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient","volume":"25","author":"Kamar","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00822-17","article-title":"Characterization of the quasi-enveloped hepatitis E virus particles released by the cellular exosomal pathway","volume":"91","author":"Nagashima","year":"2017","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib15","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1099\/vir.0.035378-0","article-title":"Tumour susceptibility gene 101 and the vacuolar protein sorting pathway are required for the release of hepatitis E virions","volume":"92","author":"Nagashima","year":"2011","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1099\/vir.0.025791-0","article-title":"A\u00a0PSAP motif in the ORF3 protein of hepatitis E virus is necessary for virion release from infected cells","volume":"92","author":"Nagashima","year":"2011","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ceb.2011.04.008","article-title":"MVB vesicle formation: ESCRT-dependent, ESCRT-independent and everything in between","volume":"23","author":"Babst","year":"2011","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1034\/j.1600-0854.2003.00072.x","article-title":"Recycling compartments and the internal vesicles of multivesicular bodies harbor most of the cholesterol found in the endocytic pathway","volume":"4","author":"M\u00f6bius","year":"2003","journal-title":"Traffic"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib19","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/tra.12260","article-title":"Hepatitis E virus enters liver cells through a dynamin-2, clathrin and membrane cholesterol-dependent pathway","volume":"16","author":"Holla","year":"2015","journal-title":"Traffic"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib20","doi-asserted-by":"crossref","first-page":"e851","DOI":"10.1371\/journal.pone.0000851","article-title":"Late endosomal cholesterol accumulation leads to impaired intra-endosomal trafficking","volume":"2","author":"Sobo","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-5956-9-5","article-title":"Plasma peptidome profiling of acute hepatitis E patients by MALDI-TOF\/TOF","volume":"9","author":"Taneja","year":"2011","journal-title":"Proteome Sci"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib22","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/hep.27938","article-title":"Apolipoprotein E and protection against hepatitis E viral infection in American non-Hispanic Blacks","volume":"62","author":"Zhang","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib23","doi-asserted-by":"crossref","first-page":"33342","DOI":"10.3402\/jchimp.v6.33342","article-title":"Acute hepatitis E presenting with clinical feature of autoimmune hepatitis","volume":"6","author":"Patel","year":"2016","journal-title":"J\u00a0Community Hosp Intern Med Perspect"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib24","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/01.CIR.98.19.2088","article-title":"Mechanism of action of fibrates on lipid and lipoprotein metabolism","volume":"98","author":"Staels","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib25","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0022-2275(20)41379-3","article-title":"The discovery and development of HMG-CoA reductase inhibitors","volume":"33","author":"Endo","year":"1992","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib26","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.bbalip.2012.11.002","article-title":"Cyclosporine A and PSC833 inhibit ABCA1 function via direct binding","volume":"1831","author":"Nagao","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jhep.2018.10.035","article-title":"Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: a multicenter, randomized, double-blind, placebo-controlled phase II trial","volume":"70","author":"Hirschfield","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib28","first-page":"641","article-title":"A\u00a0systematic review of PCSK9 inhibitors alirocumab and evolocumab","volume":"22","author":"McDonagh","year":"2016","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1527-3466.2003.tb00104.x","article-title":"Pharmacology of the AC AT inhibitor avasimibe (CI-1011)","volume":"21","author":"Llaver\u00edas","year":"2003","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0009-8981(97)06532-7","article-title":"Blood lipids of patients with chronic hepatitis: differences related to viral etiology","volume":"261","author":"Fabris","year":"1997","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MED.0b013e328344556e","article-title":"Dyslipidemia and lipid management in HIV-infected patients","volume":"18","author":"Lo","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib32","article-title":"Effect of hepatitis B virus (HBV) infection on lipid profile in Ghanaian patients","volume":"10","author":"Quaye","year":"2019","journal-title":"Virology (Auckl)"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.antiviral.2010.02.325","article-title":"Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors in\u00a0vitro","volume":"86","author":"Bader","year":"2010","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib34","doi-asserted-by":"crossref","first-page":"e01345","DOI":"10.1128\/mBio.01345-18","article-title":"Late endosomal\/lysosomal cholesterol accumulation is a host cell-protective mechanism inhibiting endosomal escape of influenza A virus","volume":"9","author":"K\u00fchnl","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib35","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI29383","article-title":"Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice","volume":"116","author":"Lagace","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0300-483X(86)90198-8","article-title":"Time and dose study on the response of rats to the hypolipidaemic drug fenofibrate","volume":"41","author":"Price","year":"1986","journal-title":"Toxicology"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib37","doi-asserted-by":"crossref","unstructured":"Ehrlich A, Uhl S, Ioannidis K, Hofree M, tenOever BR, Nahmias Y. The SARS-CoV-2 transcriptional metabolic signature in lung epithelium. Cell Metabolism. https:\/\/doi.org\/10.2139\/ssrn.3650499.","DOI":"10.2139\/ssrn.3650499"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib38","first-page":"3858","article-title":"Growth of human hepatoma cells lines with differentiated functions in chemically defined medium","volume":"42","author":"Nakabayashi","year":"1982","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/v8100267","article-title":"Enhanced replication of hepatitis E virus strain 47832c in an A549-derived subclonal cell line","volume":"8","author":"Schemmerer","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/jvh.12157","article-title":"An ORF1-rearranged hepatitis E virus derived from a chronically infected patient efficiently replicates in cell culture","volume":"21","author":"Johne","year":"2014","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3390\/v10060301","article-title":"Inhibition of hepatitis E virus spread by the natural compound silvestrol","volume":"10","author":"Glitscher","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01196-17","article-title":"Hepatitis C virus replication depends on endosomal cholesterol homeostasis","volume":"92","author":"Stoeck","year":"2018","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib44","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5501\/wjv.v5.i2.85","article-title":"Determination of 50% endpoint titer using a simple formula","volume":"5","author":"Ramakrishnan","year":"2016","journal-title":"World J Virol"},{"key":"10.1016\/j.jcmgh.2021.02.002_bib46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto Encyclopedia of Genes and Genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X21000357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X21000357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:26:43Z","timestamp":1762453603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X21000357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"alternative-id":["S2352345X21000357"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2021.02.002","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Cholesterol Metabolism as Efficient Antiviral Strategy Against the Hepatitis E Virus","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2021.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}